The Self-Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population

Miłosław Cnotliwy, Alina Jurewicz, Monika Gołąb-Janowska, Arkadiusz Kazimierczak, Wojciech Głazek

Abstract


Introduction: The Self-Complete of Leeds Assessment Neuropathic Symptoms and Signs (S-LANSS) questionnaire is a tool for screening patients with neuropathic pain, which can be completed without a physician’s assistance. Until now, a Polish version of the S -LANSS has not been available. The aim of the study was to translate the English version into the Polish language and to validate it for the Polish population.

Materials and methods: A total of 101 subjects; 51 with chronic neuropathic pain in the course of different neurological diseases, and 50 patients with osteoarthritis and nociceptive pain were included in the study. All of them completed a version of the S -LANSS questionnaire translated into the Polish language. Test sensitivity and speciϐicity were calculated on the basis of statistical analysis.

Results: The sensitivity of the S -LANSS scale with the cut -off of ≥11 points was 62%, and the speciϐicity was 77%. The estimated area under ROC curve AUC (95% CI) = 0.729 (0.63–0.809).

Conclusions: The Polish version of S -LANSS could be used as a tool for screening patients with neuropathic pain. The diagnosis should be conϐirmed in neurological examination and other appropriate diagnostic methods.


Keywords


neuropathic pain; screening questionnaire

Full Text:

PDF (Język Polski)

References


Haanpaa M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152(1):14 -27.

Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006;7(4):281 -9.

Bennett MI, Smith BH, Torrance N, Potter J. The S -LANSS score for identifying pain predominantly neuropathicorigin: validation for use in clinical and postal research. J Pain 2005;6(3):149 -58.

Croccu G, Sommer C, Anand P, Attal N, Baron R, Garcia -Larrea L, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010;17(8):1010 -8.

Mathieson S, Maher CG, Terwee CB, Folly de Campos T, Lin CW. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review. J Clin Epidemiol 2015;68(8):957 -66.

Attal N. Screening tool for neuropathic pain: are they adaptable in different languages and cultures? Pain Med 2010;11(7):985 -6.

Perez C, Galvez R, Insausti J, Bennett M, Ruiz M, Rejas J. Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain. Med Clin (Barc). 2006;127(13):485 -91.

Schestatsky P, Felix -Torres V, Chaves MLF, Camara -Ehlers B, Mucenic T, Caumo W, et al. Brazilian Portuguese validation of the Leeds Assessment of Neuropathic Symptoms and Signs for patients with chronic pain. PainMedicine 2011;12(10):1544-50.

Batistaki C, Lyrakos G, Drachtidi K, Stamatiou G, Kitsou MC, Kostopanagiotou G. Translation, cultural adaptation, and validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete of Leeds Assessment of Neuropathic Symptoms and Signs (S LANSS) questionnaires into the Greek language. Pain Practice 2016;16(5):552 -64.

Turkel Y, Turker H, Demir IA, Baytrak AO, Onar MK. Validation of self report of Leeds Assessment of Neuropathic Symptoms and Signs score for identiϐication of neuropathic pain in patients from northern Turkey. Adv Clin Exp Med 2014;23(4):599 -603.

Koc R, Erdemoglu AK. Validity and reliability of the Turkish Self -administered Leeds Assessment of Neuropathic Symptoms and Signs (S -LANSS) Questionnaire. Pain Med 2010;11(7):1107 -14.

Elzahaf RA, Tashani OA, Unsworth BA, Johnson MI. Translation and linguistic validation of the self completed Leeds Assessment of Neuropathic Symptoms and Signs (-LANSS) scale for use in a Libyan population. Pain Practice 2012;13(3):198 -205.

Cho SI, Lee CH, Park GH, Park CW, Kim HO. Use of S LANSS, a tool for screening neuropathic pain, for predicting post herpetic neuralgia in patients after acute herpes zoster events. A single -center, 12 -months, prospective cohort study. J Pain 2014;15(2):149 -56.

Ordeberg G. Characterisation of joint pain in human OA. In: Osteoarthric joint pain. Chichester: John Wiley & Sons; 2004 . p. 105 -21

Bisaga W, Dorazil M, Dobrogowski J, Wordliczek J. Porównanie przydatności wybranych skal oceny bólu neuropatycznego u pacjentów z przewlekłymi zespołami bólowymi: krótkie doniesienie. Med Pal Prakt 2011;5:22 -6.

Dworkin RH, O’Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85 (suppl): S3 -S14.




DOI: https://doi.org/10.21164/pomjlifesci.143

Copyright (c) 2016 Miłosław Cnotliwy, Alina Jurewicz, Monika Gołąb-Janowska, Arkadiusz Kazimierczak, Wojciech Głazek

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/